Thinle Chodon
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 25
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 3
- Immunology 18
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 6
- Co-authors
- Antoni Ribas (21 shared papers)Richard C. Koya (24 shared papers)Roger S. Lo (4 shared papers)Hubing Shi (4 shared papers)Xiangju Kong (4 shared papers)Jeffrey A. Sosman (3 shared papers)Mi‐Kyung Lee (2 shared papers)Stanley F. Nelson (2 shared papers)
- Journals
- Journal of Immunotherapy (4 papers)Cancer Discovery (3 papers)Clinical Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cancer Immunology Research (2 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Thinle Chodon
33 papers receiving 5.2k citations
Thinle Chodon's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 3.2k
- Immunology 1.4k
- Molecular Biology 3.3k
- Computational Theory and Mathematics 578
- Cancer Research 461
Countries citing papers authored by Thinle Chodon
This map shows the geographic impact of Thinle Chodon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thinle Chodon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thinle Chodon more than expected).
Fields of papers citing papers by Thinle Chodon
This network shows the impact of papers produced by Thinle Chodon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thinle Chodon. The network helps show where Thinle Chodon may publish in the future.
Co-authors
The 25 scholars most cited alongside Thinle Chodon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation Hit paper breakdown → | 2010 | 1614 |
| 2 | Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy Hit paper breakdown → | 2013 | 715 |
| 3 | Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance Hit paper breakdown → | 2012 | 470 |
| 4 | 2011 | 356 | |
| 5 | 2016 | 302 | |
| 6 | 2014 | 285 | |
| 7 | 2014 | 280 | |
| 8 | 2012 | 187 | |
| 9 | 2009 | 135 | |
| 10 | 2013 | 133 | |
| 11 | 2013 | 112 | |
| 12 | 2010 | 111 | |
| 13 | 2003 | 103 | |
| 14 | 2000 | 101 | |
| 15 | 2010 | 48 | |
| 16 | 2015 | 40 | |
| 17 | 2010 | 39 | |
| 18 | 2021 | 30 | |
| 19 | 2014 | 26 | |
| 20 | 2010 | 23 |
About Thinle Chodon
Thinle Chodon is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 33 papers that have together received 5.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Virus-based gene therapy research (8 papers), Immune Cell Function and Interaction (8 papers), Melanoma and MAPK Pathways (7 papers), T-cell and B-cell Immunology (6 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (3.2k citations), Immunology (1.4k citations), Molecular Biology (3.3k citations), Computational Theory and Mathematics (578 citations) and Cancer Research (461 citations). Thinle Chodon has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Antoni Ribas, Richard C. Koya, Roger S. Lo, Hubing Shi, Xiangju Kong, Jeffrey A. Sosman, Mi‐Kyung Lee, Stanley F. Nelson, Hane Lee and Narsis Attar. Their work appears in journals such as Journal of Immunotherapy, Cancer Discovery, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.